1. Vernaza, Alexandra, Cardus, Daniela F, Smith, Jadyn L, Zhao, Zhenze, Du, Liqin. 2024. Identification of CDKN3 as a Key Gene that Regulates Neuroblastoma Cell Differentiation. In Journal of Cancer, 15, 1153-1168. doi:10.7150/jca.89660. https://pubmed.ncbi.nlm.nih.gov/38356706/
2. Abdel-Tawab, Marwa Sayed, Fouad, Hanan, Othman, Asmaa M, Hassan, Ahmed, Reyad, Hoda Ramadan. 2022. Evaluation of gene expression of PLEKHS1, AADAC, and CDKN3 as novel genomic markers in gastric carcinoma. In PloS one, 17, e0265184. doi:10.1371/journal.pone.0265184. https://pubmed.ncbi.nlm.nih.gov/35446856/
3. Zang, Xiao, Chen, Min, Zhou, Yunyun, Xie, Yang, Wang, Xinlei. 2015. Identifying CDKN3 Gene Expression as a Prognostic Biomarker in Lung Adenocarcinoma via Meta-analysis. In Cancer informatics, 14, 183-91. doi:10.4137/CIN.S17287. https://pubmed.ncbi.nlm.nih.gov/26052221/
4. Cress, W Douglas, Yu, Peng, Wu, Jie. 2017. Expression and alternative splicing of the cyclin-dependent kinase inhibitor-3 gene in human cancer. In The international journal of biochemistry & cell biology, 91, 98-101. doi:10.1016/j.biocel.2017.05.013. https://pubmed.ncbi.nlm.nih.gov/28504190/
5. Barrón, Eira Valeria, Roman-Bassaure, Edgar, Sánchez-Sandoval, Ana Laura, Pérez-Armendariz, E Martha, Berumen, Jaime. 2015. CDKN3 mRNA as a Biomarker for Survival and Therapeutic Target in Cervical Cancer. In PloS one, 10, e0137397. doi:10.1371/journal.pone.0137397. https://pubmed.ncbi.nlm.nih.gov/26372210/
智鼠故事 
